Lipella Pharmaceuticals, Inc. (LIPO)
Lipella Pharmaceuticals Market Cap: 0.9935M for Jan. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| CEL-SCI Corp. | 15.93M |
| AIM ImmunoTech, Inc. | 3.471M |
| IGC Pharma, Inc. | 26.01M |
| NovaBay Pharmaceuticals, Inc. | 820.13M |
| Protalix Biotherapeutics, Inc. | 164.86M |
Market Cap Related Metrics
| PS Ratio | 1.671 |
| Price to Book Value | 0.6678 |
| Price | 0.215 |
| Earnings Yield | -1.12K% |